1335 related articles for article (PubMed ID: 16879242)
1. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
[TBL] [Abstract][Full Text] [Related]
2. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
[TBL] [Abstract][Full Text] [Related]
4. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
[TBL] [Abstract][Full Text] [Related]
5. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
6. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis.
Wilde B; Dolff S; Cai X; Specker C; Becker J; Tötsch M; Costabel U; Dürig J; Kribben A; Tervaert JW; Schmid KW; Witzke O
Nephrol Dial Transplant; 2009 Jan; 24(1):161-71. PubMed ID: 18723571
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q
Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711
[TBL] [Abstract][Full Text] [Related]
9. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
10. Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.
Wong CK; Lit LC; Tam LS; Li EK; Lam CW
Rheumatology (Oxford); 2005 Aug; 44(8):989-94. PubMed ID: 15870153
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.
Dolff S; Quandt D; Wilde B; Feldkamp T; Hua F; Cai X; Specker C; Kribben A; Kallenberg CG; Witzke O
Arthritis Res Ther; 2010; 12(4):R150. PubMed ID: 20653937
[TBL] [Abstract][Full Text] [Related]
12. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
13. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
Takasaki Y; Ogaki M; Abe K; Takeuchi K; Ando S; Tokano Y; Kobayashi S; Sekigawa I; Tsuda H; Hashimoto H
J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
[TBL] [Abstract][Full Text] [Related]
14. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.
Enghard P; Humrich JY; Rudolph B; Rosenberger S; Biesen R; Kuhn A; Manz R; Hiepe F; Radbruch A; Burmester GR; Riemekasten G
Arthritis Rheum; 2009 Jan; 60(1):199-206. PubMed ID: 19116922
[TBL] [Abstract][Full Text] [Related]
15. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
Azab NA; Bassyouni IH; Emad Y; Abd El-Wahab GA; Hamdy G; Mashahit MA
Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
[TBL] [Abstract][Full Text] [Related]
18. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
Bertsias GK; Nakou M; Choulaki C; Raptopoulou A; Papadimitraki E; Goulielmos G; Kritikos H; Sidiropoulos P; Tzardi M; Kardassis D; Mamalaki C; Boumpas DT
Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
[TBL] [Abstract][Full Text] [Related]
19. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating CD4+ ICOS+ Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus.
Liu Y; Zhu T; Cai G; Qin Y; Wang W; Tang G; Zhao D; Shen Q
Lupus; 2011 May; 20(6):620-7. PubMed ID: 21558138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
